Fighting AIDS and Pricing Drugs Harvard Case Solution & Analysis

In early 2001, manufacturers of AIDS drugs were judged to prevent developing countries from violating its patents. This issue was due to the price. Developing countries can not afford market prices for these products. At the same time, pharmaceutical companies are reluctant to sell drugs at or below the cost in one country, and 10 to 20 times the value in the other country. Using a series of articles published, this case describes the pressures facing the pharmaceutical companies, and asks the question "How would they react?"
This case is only available in paper format (HBP do not have the rights to distribute digital content). As a result, a digital copy of an educator if not available through this Web site. "Hide
by John T. Gourville Source: Harvard Business School 14 pages. Publication Date: February 26, 2002. Prod. # 502 061-HCB-ENG

Fighting AIDS and Pricing Drugs Case Solution Other Similar Case Solutions like

Fighting AIDS and Pricing Drugs

Share This